Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMTP1-ICG Mapping in Colposcopy-directed Biopsy
NCT03321461Phase 1Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Nov 2017
- Primary completion
- Aug 2020
- Modality
- Light/Condition-Responsive Prodrugs, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of TMTP1-ICG in cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Sensitivity at 1 day. Status: unknown.
02
Drugs
TMTP1-ICG
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT03321461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321461.